Biotax SB 250 mg/125 mg Injection
By Biotax SB
Rx
1 Injection in a Vial

Composition
Cefotaxime(250mg) + Sulbactam(125mg)

Manufacturer - Zydus Healthcare Limited
Zydus Tower, CTS No- 460/6 of Village Pahadi, Off I. B. Patel Road, Goregaon (East), Mumbai-400 063

Expires on or after
September, 2025

liver
Limited information is available regarding the safety of Biotax SB 250 mg/125 mg Injection in patients with liver disease. It is advised to consult your doctor before using this medication if you have any liver issues. Your doctor will be able to assess the potential risks and benefits specific to your condition and provide appropriate guidance.

kidney
Caution Biotax SB 250 mg/125 mg Injection may require dose adjustment in patients with kidney disease. Consult your doctor for guidance. Monitoring kidney function is recommended during treatment.

alcohol
Caution is advised when combining alcohol with Biotax SB 250 mg/125 mg Injection. It is recommended to consult your doctor for guidance on alcohol consumption while using this medication.

driving
Biotax SB 250 mg/125 mg Injection can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Biotax SB 250 mg/125 mg Injection is typically safe to use during pregnancy based on animal studies indicating minimal harm to the fetus. Limited human studies are available.

breastfeeding
Biotax SB 250 mg/125 mg Injection is considered safe for breastfeeding. Research shows it does not pass into breastmilk in harmful levels and is unlikely to harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹20
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024